Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32328561

Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JNCI Cancer Spectr
Publication date
2020 Apr
First author
Piha-Paul SA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    doi: 10.1093/jncics/pkz092
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null
  2. citation
    doi: 10.1093/jncics/pkz094
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null

Authors and identifiers

  1. name
    Piha-Paul SA
    type
    Author
  2. name
    Hann CL
    type
    Author
  3. name
    French CA
    type
    Author
  4. name
    Cousin S
    type
    Author
  5. name
    Braña I
    type
    Author
  6. name
    Cassier PA
    type
    Author
  7. name
    Moreno V
    type
    Author
  8. name
    de Bono JS
    type
    Author
  9. name
    Harward SD
    type
    Author
  10. name
    Ferron-Brady G
    type
    Author
  11. name
    Barbash O
    type
    Author
  12. name
    Wyce A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Piha-Paul SA
    type
    Author
  2. name
    Hann CL
    type
    Author
  3. name
    French CA
    type
    Author
  4. name
    Cousin S
    type
    Author
  5. name
    Braña I
    type
    Author
  6. name
    Cassier PA
    type
    Author
  7. name
    Moreno V
    type
    Author
  8. name
    de Bono JS
    type
    Author
  9. name
    Harward SD
    type
    Author
  10. name
    Ferron-Brady G
    type
    Author
  11. name
    Barbash O
    type
    Author
  12. name
    Wyce A
    type
    Author
bibliography ids
  1. nci-bib-42285b8e83b5c6086702c166
book metadata
content sha256
b70561d70f12fa11b520dba3cdb66dbccf9174a103f28ec997345a43808e9bc0
document type
citation
dois
  1. 10.1093/jncics/pkz093
electronic publication date
display
2019 Nov 6
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:32328561
immutable id
pubmed:32328561@b70561d70f12fa11b520dba3cdb66dbccf9174a103f28ec997345a43808e9bc0
journal
abbreviation
JNCI Cancer Spectr
issn electronic
2515-5091
issn print
Source null
issue
2
name
JNCI cancer spectrum
nlm unique id
101721827
pages
pkz093
volume
4
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    doi: 10.1093/jncics/pkz092
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null
  2. citation
    doi: 10.1093/jncics/pkz094
    note
    Source null
    related pmid
    Source null
    relationship
    Comment in
    url
    Source null
outcomes validated
false
pmid
32328561
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
ede5f1466be164a1b611729bbea3f78078fe5bd48e64db4e95cf30bd564bf3be
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Apr
precision
month
year
2020
publication types
  1. Journal Article
record status
PubMed
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32328561/
title
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

Preserved source evidence · Not medical advice